Trevena Inc TRVN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:27 AM EDT
0.4001quote price arrow down-0.0094 (-2.2955%)
Volume
9,345
52 week range
0.30 - 3.28
Loading...
  • Open0.4352
  • Day High0.4352
  • Day Low0.4001
  • Prev Close0.4095
  • 52 Week High3.28
  • 52 Week High Date05/08/23
  • 52 Week Low0.30
  • 52 Week Low Date04/02/24

Key Stats

  • Market Cap7.33M
  • Shares Out18.32M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta1.07
  • YTD % Change-43.53

KEY STATS

  • Open0.4352
  • Day High0.4352
  • Day Low0.4001
  • Prev Close0.4095
  • 52 Week High3.28
  • 52 Week High Date05/08/23
  • 52 Week Low0.30
  • 52 Week Low Date04/02/24
  • Market Cap7.33M
  • Shares Out18.32M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta1.07
  • YTD % Change-43.53

RATIOS/PROFITABILITY

  • EPS (TTM)-3.16
  • P/E (TTM)-0.13
  • Fwd P/E (NTM)-0.24
  • EBITDA (TTM)-34.954M
  • ROE (TTM)-1,014.58%
  • Revenue (TTM)3.125M
  • Gross Margin (TTM)46.56%
  • Net Margin (TTM)-1,289.25%
  • Debt To Equity (MRQ)-402.59%

EVENTS

  • Earnings Date05/13/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Trevena Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of medicines for patients with central nervous system (CNS) disorders. The Company has one approved product in the United States, OLINVYK (oliceridine) injection, indicated in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate. The Company’s pipeline includes three differentiated...
Carrie Bourdow
Chairman of the Board, President, Chief Executive Officer
Barry Shin J.D.
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Address
955 Chesterbrook Boulevard, Suite 110
Chesterbrook, PA
19087
United States

Top Peers

SYMBOLLASTCHG%CHG
ACUR
Acura Pharmaceuticals Inc
0.003UNCHUNCH
INFIQ
Infinity Pharmaceuticals Inc
0.00UNCHUNCH
EVOK
Evoke Pharma Inc
0.43-0.0277-6.052%
GTBP
GT Biopharma Inc
3.35+0.16+4.85%
NAVB
Navidea Biopharmaceuticals Inc
0.035UNCHUNCH